New AI tools set to advance early cancer detection and prevention
Birmingham researchers are to play a role in Cancer Research UK’s recently announced £10 million AI detection programme, jointly supported by the National Institute for Health and Care Research (NIHR…
Researchers at the Royal Orthopaedic Hospital secure funding to develop cancer-killing injectable paste for bone tumours
The Dubrowsky Lab at BHP member the Royal Orthopaedic Hospital (ROH) has secured a £110k grant from Orthopaedic Research UK to develop an injectable paste with anticancer and bone regenerative proper…
Aston University and Birmingham Children’s Hospital study shows diagnosis and treatment of preschool wheeze needs improvement
A study led by Aston University’s Dr Gemma Heath and Dr Prasad Nagakumar from Birmingham Children’s Hospital – both BHP member organisations – has shown that treatment and diagnosis for preschool wh…
Increasing transparency and tackle potential bias in medical AI technologies: BHP researchers publish new recommendations
Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally agreed recommendations – published in The Lancet Digital Health and NE…
£3.4m boost for research into paediatric autoimmune brain inflammation
Dr Sukhvir Wright at Aston University’s Institute for Health and Neurodevelopment (IHN) and Honorary Consultant Neurologist at Birmingham Children’s Hospital (BCH) – both BHP member organisations – h…
Central and North West Midlands Awarded Prestigious NIHR Commercial Research Delivery Centre
Birmingham Health Partners (BHP) has successfully led a bid to establish one of the UK’s new National Institute for Health and Care Research (NIHR) Commercial Research Delivery Centres (CRDCs) to exp…